Abstract
This paper explores how resources are controlled and combined in a biotech network that spans from Uppsala, Sweden, to Stanford, USA. A case study is reported that describes and analyses how the original discovery, developed at the Department of Genetics and Pathology at Uppsala University, Sweden, was combined with other innovations at Stanford University, California, and under the influence and control of several different actors, including venture capitalists, were exploited within a newly founded company, ParAllele. The paper analyzes the resources that are created, combined and controlled in the network around these scientific discoveries and the company hosting them. This analysis shows how actors are using and are exposed to different control mechanisms, such as action, results and personnel controls, in the innovation process. Our discussion emphasizes how the involved actors apply various types of controls on resources in order to reach their objectives. Forms of control that both entail mobilizing other actors and preventing actions in the emerging network are of importance. We conclude the paper by pointing out the features of control in innovation processes as well as obstacles to control in a business network setting.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have